Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Zunhan Shi"'
Publikováno v:
Frontiers in Physiology, Vol 13 (2022)
Atherosclerosis is the hallmark of cardiovascular disease (CVD) which is a leading cause of death in type 2 diabetes patients, and glycemic control is not beneficial in reducing the potential risk of CVD. Clinically, it was shown that Thiazolidinedio
Externí odkaz:
https://doaj.org/article/153896699bba4f75a529c603ad3a0ce5
Publikováno v:
Biomolecules, Vol 12, Iss 12, p 1832 (2022)
The number of patients with type 2 diabetes mellitus (T2DM), which is mainly characterized by insulin resistance and insulin secretion deficiency, has been soaring in recent years. Accompanied by many other metabolic syndromes, such as cardiovascular
Externí odkaz:
https://doaj.org/article/8437a760ab8c487bb124d97839618439
Exercise Promotes Bone Marrow Microenvironment by Inhibiting Adipsin in Diet-Induced Male Obese Mice
Autor:
Zunhan Shi, Lihui Wang, Jinwen Luan, Liqin Yin, Xiaohui Ji, Wenqian Zhang, Bingxiang Xu, Linshan Chen, Ying He, Ru Wang, Longhua Liu
Publikováno v:
Nutrients; Volume 15; Issue 1; Pages: 19
Obesity is a growing global epidemic linked to many diseases, including diabetes, cardiovascular diseases, and musculoskeletal disorders. Exercise can improve bone density and decrease excess bone marrow adipose tissue (BMAT) in obese individuals. Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21eedbe4c7efc4c37bdc122d5483a3e5
Publikováno v:
Cellular and Molecular Life Sciences. 79
Characterized by a surplus of whole-body adiposity, obesity is strongly associated with the prognosis of atherosclerosis, a hallmark of coronary artery disease (CAD) and the major contributor to cardiovascular disease (CVD) mortality. Adipose tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655cff3531273f2afbd952c723bc3fa9
https://doi.org/10.1007/s00018-022-04286-2
https://doi.org/10.1007/s00018-022-04286-2
Publikováno v:
Frontiers in physiology. 13
Atherosclerosis is the hallmark of cardiovascular disease (CVD) which is a leading cause of death in type 2 diabetes patients, and glycemic control is not beneficial in reducing the potential risk of CVD. Clinically, it was shown that Thiazolidinedio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae84fb570104cd469bd430b6611d9a29
https://pubmed.ncbi.nlm.nih.gov/35309069
https://pubmed.ncbi.nlm.nih.gov/35309069